Recurrent ischemic events after successful thrombolysis in acute myocardial infarction. The Achilles' heel of thrombolytic therapy.

This publication has 28 references indexed in Scilit:

• Thrombolytic Therapy: Current Status
  New England Journal of Medicine, 1988
• Infarct vessel status after intravenous tissue plasminogen activator and acute coronary angioplasty: Prediction of clinical outcome
  American Heart Journal, 1988
• A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
  New England Journal of Medicine, 1987
• Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: Initial patency and influence of maintained infusion on reocclusion rate
  The American Journal of Cardiology, 1987
• Assessment of residual coronary arterial stenosis after thrombolytic therapy during acute myocardial infarction
  The American Journal of Cardiology, 1987
• Usefulness of recanalization to luminal diameter of 0.6 millimeter or more with intracoronary streptokinase during acute myocardial infarction in predicting “normal” perfusion status, continued arterial patency and survival at one year
  The American Journal of Cardiology, 1987
• The Effect of Heparin and Fibrin on the Enzymatic Efficiencies of Thrombolytics in Vitro
  Drugs, 1987
• Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction
  New England Journal of Medicine, 1985
• Effects of Intracoronary Streptokinase and Intracoronary Nitroglycerin Infusion on Coronary Angiographic Patterns and Mortality in Patients with Acute Myocardial Infarction
  New England Journal of Medicine, 1984
• Percutaneous transluminal coronary angioplasty: Application for acute myocardial infarction
  The American Journal of Cardiology, 1984